EUVIMEDEUVIMED entdecken
Crossref

TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?

Teiji Akagi, Mitsutaka Nakashima, Takao Morikawa, Yoichi Takaya, Atsushi Hirohata

JACC · 2026-11 · 88 (18) · B126

DOI: 10.1016/j.jacc.2026.09.385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Teiji Akagi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Akagi, T., Nakashima, M., Morikawa, T., Takaya, Y., & Hirohata, A. (2026). TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?. JACC, 88(18), B126. https://doi.org/10.1016/j.jacc.2026.09.385

Vancouver

Akagi T, Nakashima M, Morikawa T, Takaya Y, Hirohata A. TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?. JACC. 2026;88(18):B126. doi:10.1016/j.jacc.2026.09.385

BibTeX
@article{Akagi2026,
  author = {Akagi, Teiji and Nakashima, Mitsutaka and Morikawa, Takao and Takaya, Yoichi and Hirohata, Atsushi},
  title = {TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?},
  journal = {JACC},
  year = {2026},
  volume = {88},
  number = {18},
  pages = {B126},
  doi = {10.1016/j.jacc.2026.09.385}
}
Kostenlos starten →